Depuis le démarrage de notre activité de capital - investissement en 1989, nous avons investi dans plus de 335 sociétés réparties dans 40 pays.
| Société | Pays | Secteur | Description | Type de deal | Date de l'investissement | |
|---|---|---|---|---|---|---|
 |
Zentiva | Pays Czech Republic | Secteur Santé | Description A leading European generics pharmaceutical company, offering generic medicines across all key therapeutic areas | Type de deal Détourage | Date de l'investissement Sep 2018 |
 |
Genoa Healthcare | Pays US | Secteur Santé | Description Largest specialty pharmacy operator in the US focusing primarily on serving the needs of the mental health community | Type de deal Buyout | Date de l'investissement Apr 2015 |
 |
Mediq | Pays Netherlands | Secteur Santé | Description Global provider of pharmaceuticals, medical devices and related care services | Type de deal Public-to-private | Date de l'investissement Feb 2013 |
 |
Grupo Biotoscana | Pays Colombia | Secteur Santé | Description Specialty pharmaceutical company licensing innovative and niche products to market in Latin America | Type de deal Buyout | Date de l'investissement Nov 2011 |
 |
Laboratorio LKM | Pays Argentina | Secteur Santé | Description One of the leading specialty pharmaceutical manufacturers in Argentina | Type de deal Buyout | Date de l'investissement Oct 2011 |
 |
Labormed | Pays Romania | Secteur Santé | Description Romanian pharmaceutical manufacturer and distributor | Type de deal Buyout | Date de l'investissement Feb 2008 |
 |
Terapia | Pays Romania | Secteur Santé | Description Romania's largest independent generic pharmaceuticals manufacturer | Type de deal Public-to-private | Date de l'investissement Aug 2003 |
 |
Aviagen | Pays UK | Secteur Santé | Description World's leading meat poultry breeding company | Type de deal Buyout | Date de l'investissement May 2003 |
 |
Viatris | Pays Germany | Secteur Santé | Description Development, manufacturing, distribution and in-licensing of branded pharmaceuticals | Type de deal Buyout | Date de l'investissement Aug 2002 |
 |
Fada Pharma | Pays Argentina | Secteur Santé | Description Argentina's leading manufacturer of generic pharmaceuticals for the institutional market | Type de deal Buyout | Date de l'investissement Jan 2001 |
 |
Tropon | Pays Germany | Secteur Santé | Description Toll manufacturer and supplier of drugs for inflammatory and rheumatoid disorders (acquired by Advent portfolio company Viatris) | Type de deal Buyout | Date de l'investissement Mar 2000 |
 |
Alcala Farma | Pays Spain | Secteur Santé | Description Manufacturer and marketer of own and in-licensed pharmaceuticals, branded generics and over-the-counter products | Type de deal Growth equity | Date de l'investissement Sep 1999 |
 |
Trinity Pharmaceuticals | Pays UK | Secteur Santé | Description Co-development, licensing and marketing of branded pharmaceuticals, mainly for cardiovascular and arthritic indications | Type de deal Buyout | Date de l'investissement Mar 1997 |
 |
3i - Implant Innovations Inc. | Pays US | Secteur Santé | Description Manufacturer of dental implants | Type de deal Growth equity | Date de l'investissement May 1995 |
 |
Telik | Pays US | Secteur Santé | Description Developer of novel pharmaceuticals to treat cancer and metabolic diseases (merged with MabVax Therapeutics) | Type de deal Growth equity | Date de l'investissement Nov 1994 |
 |
Esaote Biomedica | Pays Italy | Secteur Santé | Description Research, production and marketing of imaging and non-imaging medical diagnostic equipment | Type de deal Buyout | Date de l'investissement Jul 1994 |
 |
Transcend Therapeutics | Pays US | Secteur Santé | Description Company formed to develop novel pharmaceuticals for the critical-care market | Type de deal Growth equity | Date de l'investissement Apr 1994 |
© 2002-2019 Advent International Corporation. All rights reserved
